Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Breast Neoplasms 2Skin Carcinoma 1Pancreatic Neoplasms 1Pancreatic Cancer Liver Metastases 1Malignant Solid Neoplasm 1Malignant Female Reproductive System Neoplasm 1Leukemia, Myeloid, Acute 1Hereditary Breast and Ovarian Cancer Syndrome 1Hepatitis B, Chronic 1Hemorrhage 1Disease 1Colorectal Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Carcinoma, Hepatocellular 1Anastomotic Leak 1Adenoma, Islet Cell 1

Interventions

Methods 1Immunotherapy 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Cancer Liver Metastases × Methods × Clear all
NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Shandong Provincial Hospital

Phase 2 Not yet recruiting
38 enrolled
Gastrointestinal

Pancreatic Cancer Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡